COV

Pardes Biosciences Reports First Quarter 2022 Financial Results and Provides Business Update

Retrieved on: 
Tuesday, May 10, 2022
Board, COVID-19, Forward-looking statement, CROI, Private Securities Litigation Reform Act, Regulation Fair Disclosure, Insurance, IND, NASDAQ, GLOBE, RNA, Regulation, Public expenditure, Research, Safety, Disclosure, Sustainability Accounting Standards Board, Security (finance), Coronavirus, Infection, Program, DAA, FDA, Annual report, ICAR, NCT, International Conference on Emerging Infectious Diseases, U.S. Securities and Exchange Commission, Severe acute respiratory syndrome coronavirus 2, Antiviral Research, COV, Intention, Subclinical infection, BID, Conference, PRDS, SEC, CEO, Investor, Pharmaceutical industry, Pardes

Presented preclinical and clinical updates for PBI-0451 at multiple international scientific conferences: In February 2022, Pardes presented data at the 29th Conference on Retroviruses and Opportunistic Infections (CROI) 2022.

Key Points: 
  • Presented preclinical and clinical updates for PBI-0451 at multiple international scientific conferences: In February 2022, Pardes presented data at the 29th Conference on Retroviruses and Opportunistic Infections (CROI) 2022.
  • In March 2022, Pardes presented data at the 35th International Conference on Antiviral Research (ICAR) 2022.
  • Pardes reported a net loss of $21.4 million for the quarter ended March 31, 2022, as compared to a net loss of $4.5 million for the quarter ended March 31, 2021.
  • Research and development expenses were $13.2 million for the quarter ended March 31, 2022, compared to $3.4 million for the quarter ended March 31, 2021, an increase of $9.8 million.

Covalon Announces New Senior Vice President of Marketing

Retrieved on: 
Tuesday, April 26, 2022
COV, News, Health, Marketing, Hemostasis, COVID-19, Research, Saudi Aramco Medical Services Organization, MD, Communication, TSX Venture Exchange, Regenerative medicine, Hematology, Company, NYSE, Beckman Coulter, Physician, Industry, Multimedia, Risk, Senior, Pharmaceutical industry

MISSISSAUGA, ON, April 26, 2022 /PRNewswire/ - Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV) (OTCQX: CVALF), an advanced medical technologies company, today announced that Ron Hebert has joined the Company as Senior Vice President of Marketing.

Key Points: 
  • MISSISSAUGA, ON, April 26, 2022 /PRNewswire/ - Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV) (OTCQX: CVALF), an advanced medical technologies company, today announced that Ron Hebert has joined the Company as Senior Vice President of Marketing.
  • "We are so pleased to welcome Ron to Covalon," said Brian Pedlar, Chief Executive Officer of Covalon.
  • Prior to joining the Company, he served as Vice President of Marketing and Communications at VIVEX Biologics, a regenerative medicine technology company based in Florida.
  • He also served as Vice President and Head of Growth Marketing and Sales Operations at MEDNAX (NYSE: MD) Health Solutions, a $3.5 billion Physician Services Organization.

Nielsen: ONE Championship Ranks Top 5 for Global Viewership and Engagement Among All Major Sports Properties

Retrieved on: 
Monday, April 25, 2022
NFL, NET, Sport, TikTok, AbemaTV, Courage, Population, COVID-19, Spark New Zealand, UFC, Martial arts, Match TV, Gen, Star Sports, IB, YouTube, La Liga, Television, Formula One Esports Series, TAM, EPL, UCL, Growth, IQIYI, Mediacorp, UEFA, Nike Vaporfly and Tokyo 2020 Olympics Controversy, One Sports, ONE, RedeTV!, Thairath TV, Instagram, UEFA Champions League, Beijing Media Network, Multimedia, BARB, COV, NBA, Dubai Sports, Animal, Skynet, Review, Nielsen, F1, Facebook

SINGAPORE, April 25, 2022 /PRNewswire/ -- ONE Championship™ (ONE) ranks top five in viewership and engagement among all major global sports properties, according to a recent report by Nielsen titled, "Year in Review: Sports Consumption Evolution."

Key Points: 
  • SINGAPORE, April 25, 2022 /PRNewswire/ -- ONE Championship (ONE) ranks top five in viewership and engagement among all major global sports properties, according to a recent report by Nielsen titled, "Year in Review: Sports Consumption Evolution."
  • It sits just behind the #1-ranked NBA, which boasts over 14.5 billion for 2021.
  • ONE also ranked #4 on YouTube, #11 on TikTok, and #17 on Instagram in average engagements per post.
  • According to Nielsen, ONE ranks amongst the world's top 5 biggest sports media properties for viewership and engagement.

Pardes Biosciences Reports Full Year 2021 Financial Results and Provides Business Update

Retrieved on: 
Tuesday, March 29, 2022
Cell, Regulation, Foresite Capital, Safety, NASDAQ, Interim, Investor, COV, Pharmacokinetics, Coronavirus, Board, Public expenditure, IND, SPAC, Program, Subclinical infection, The Conference Board, DAA, CROI, Conference, PIPE, CEO, RNA, Severe acute respiratory syndrome coronavirus 2, Antiviral Research, Senior, ICAR, NCT, Regulation Fair Disclosure, Disclosure, COVID-19, U.S. Securities and Exchange Commission, GLOBE, NDA, Erik De Clercq, Infection, International Conference on Emerging Infectious Diseases, BID, FSII, FDA, Key, PRDS, Science, Acquisition, Security (finance), Pharmaceutical industry, Management, Cryptocurrency, Research, Pardes

Completed Business Combination with FS Development Corp. II: In December 2021, Pardes completed its business combination with FS Development Corp. II (FSII), a special purpose acquisition company (SPAC) sponsored by Foresite Capital.

Key Points: 
  • Completed Business Combination with FS Development Corp. II: In December 2021, Pardes completed its business combination with FS Development Corp. II (FSII), a special purpose acquisition company (SPAC) sponsored by Foresite Capital.
  • Strengthened Leadership Team with Key Additions: Pardes has grown its executive and senior leadership team with several key appointments across manufacturing, research, and business development.
  • Significant hires include:
    Valdas Jurkauskas, Ph.D.: Pardes appointed Valdas Jurkauskas as Senior Vice President of Technical Operations.
  • Accordingly, investors should monitor Pardes Biosciences Investors website, in addition to following Pardes press releases, Securities and Exchange Commission filings, public conference calls, presentations and webcasts.

Covalon Announces Changes to its Board of Directors

Retrieved on: 
Thursday, March 10, 2022
Government, Industry, Community, Child, Tropical medicine, University, Risk, Company, McMaster University, COV, Royal college, Woman, FRCPC, Centre for History in Public Health, London School of Hygiene and Tropical Medicine, London School of Medicine for Women, Physician, MD, Order of Ontario, Health, News, Multimedia, College, Board, Board of directors, Master of Science, Order, Royal College of Physicians and Surgeons of Canada, Fellow, CCFP, TSX Venture Exchange, TSX, Knowledge, Public health, COVID-19, Surgeon, War Child (charity), Women's College Hospital, Assistant, FCPC, Management, Pharmaceutical industry, Hygiene, Medicine

Dr. Nutt has been appointed to the Order of Canada and is a recipient of the Order of Ontario.

Key Points: 
  • Dr. Nutt has been appointed to the Order of Canada and is a recipient of the Order of Ontario.
  • "We are delighted that Dr. Nutt has joined Covalon's Board," said Brian Pedlar, Chief Executive Officer.
  • "Her specialized medical expertise and extraordinary philanthropic achievements will be a tremendous asset to Covalon."
  • Amir Boloor, Chair of Covalon's Board of Directors, said, "We are extremely grateful for Marty's numerous contributions as a Director, supporter, and mentor to Covalon for many years.

Covalon Announces Conference Call to Discuss First Quarter Fiscal 2022 Financial Results

Retrieved on: 
Wednesday, February 16, 2022
TSX Venture Exchange, Webcast, Risk, Company, News, Baozou Big News Events, SEDAR, COV, MD, Q&A, Mission statement, Industry, Multimedia, COVID-19, Investor, Risk management

MISSISSAUGA, ON, Feb. 16, 2022 /PRNewswire/ - Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV) (OTCQX: CVALF), an advanced medical technologies company, will release its Q1 Fiscal 2022 financial results on Tuesday March 1st, 2022, before markets open.

Key Points: 
  • MISSISSAUGA, ON, Feb. 16, 2022 /PRNewswire/ - Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV) (OTCQX: CVALF), an advanced medical technologies company, will release its Q1 Fiscal 2022 financial results on Tuesday March 1st, 2022, before markets open.
  • A conference call and webcast to discuss the financial results will be held on Tuesday, March 1st, 2022, at 9:00am EST.
  • A recording of the call will be available by calling 1-888-390-0541 or 416-764-8677 and entering the encore replay entry code 526078# until March 15th, 2022.
  • Copies of Covalon's financial statements and MD&A can be obtained on SEDAR at www.sedar.com and under Sedar Filings on the Investors tab of Covalon's website.

Covesting Announces COV-Denominated Strategy And Margin Accounts On PrimeXBT

Retrieved on: 
Tuesday, February 15, 2022
Covesting, BTC, Growth, Blog, COV, ETH, USDT, DLT, USDC, Partnership, B2B, Cryptocurrency

GIBRALTAR, Feb. 15, 2022 /PRNewswire/ -- Covesting, a Europe-based, licensed DLT services provider and B2B software developer, has announced the debut of new COV-denominated margin trading accounts and copy trading strategy manager accounts.

Key Points: 
  • GIBRALTAR, Feb. 15, 2022 /PRNewswire/ -- Covesting, a Europe-based, licensed DLT services provider and B2B software developer, has announced the debut of new COV-denominated margin trading accounts and copy trading strategy manager accounts.
  • Covesting has launched its latest product development roadmap milestone, enabling new COV-denominated account types in partnership with the advanced PrimeXBT trading platform.
  • COV tokens can now be used alongside BTC, ETH, USDT, and USDC to create and fund a Covesting copy trading strategy manager account and as collateral for margin trading accounts to access more than 50 different trading instruments across crypto, forex, stock indices, and commodities.
  • COV-denominated Covesting copy trading strategy manager accounts and COV-denominated margin trading accounts are now live on partner platform PrimeXBT.

Covesting Announces COV-Denominated Strategy And Margin Accounts On PrimeXBT

Retrieved on: 
Tuesday, February 15, 2022
Covesting, BTC, Growth, Blog, COV, ETH, USDT, DLT, USDC, Partnership, B2B, Cryptocurrency

GIBRALTAR, Feb. 15, 2022 /PRNewswire/ -- Covesting, a Europe-based, licensed DLT services provider and B2B software developer, has announced the debut of new COV-denominated margin trading accounts and copy trading strategy manager accounts.

Key Points: 
  • GIBRALTAR, Feb. 15, 2022 /PRNewswire/ -- Covesting, a Europe-based, licensed DLT services provider and B2B software developer, has announced the debut of new COV-denominated margin trading accounts and copy trading strategy manager accounts.
  • Covesting has launched its latest product development roadmap milestone, enabling new COV-denominated account types in partnership with the advanced PrimeXBT trading platform.
  • COV tokens can now be used alongside BTC, ETH, USDT, and USDC to create and fund a Covesting copy trading strategy manager account and as collateral for margin trading accounts to access more than 50 different trading instruments across crypto, forex, stock indices, and commodities.
  • COV-denominated Covesting copy trading strategy manager accounts and COV-denominated margin trading accounts are now live on partner platform PrimeXBT.

Once Controversial Black Owned Clothing Brand, Personal Advisory to Premiere It's Spring/Summer Line at Agenda Show 2022

Retrieved on: 
Monday, January 24, 2022
CNN, Interview, Pullover, COV, Eye, Golden age hip hop, Intention, Clothing, Rugby shirt, Nightclub, Parkas

ATLANTA, Jan. 24, 2022 /PRNewswire/ -- Years ago, clothing brand Personal Advisory was contentiously requested to discontinue a design that seemed to depict Muslims bowing to a deejay.

Key Points: 
  • ATLANTA, Jan. 24, 2022 /PRNewswire/ -- Years ago, clothing brand Personal Advisory was contentiously requested to discontinue a design that seemed to depict Muslims bowing to a deejay.
  • Personal Advisory is influenced by Golden Age Hip Hop, Pan Africanism, mid unisex and high fashion men's street style.
  • Personal Advisory was founded in Atlanta, GA but relocated to Brooklyn in 2017 and has now settled back in Atlanta post COV.
  • Recently, Personal Advisory has caught the eye of the highly competitive Agenda Show and will be in attendance February 15th - 17th, 2022 in Las Vegas, Nevada.

Sierra Metals Announces Positive Updated PEA on the Expansion at Its Yauricocha Mine in Peru

Retrieved on: 
Thursday, January 20, 2022
Mining, Minerals, Natural Resources, Resource management, Net smelter return, News, COV, Arsenic, Copper, File, Corporation, Silver, National instrument, Plan, Canadian Institute of Mining, Metallurgy and Petroleum, Risk, NSR, Mining, Gold, Mining engineering, Mineral, U.S. Securities and Exchange Commission, Goal, Phrase, Company, Zinc, NI, Metallurgy, Lead, Lead oxide, Sierra (metal band), Oil, Risk management, Petroleum

Silver, gold, silver, copper, lead, zinc, arsenic (deleterious) and iron assays were capped / cut where appropriate.

Key Points: 
  • Silver, gold, silver, copper, lead, zinc, arsenic (deleterious) and iron assays were capped / cut where appropriate.
  • (3) The consolidated Yauricocha Resource Estimate is comprised of Measured, Indicated and inferred material in the Mina Central, Cuerpos Pequeos, Cuye, Mascota, Esperanza and Cachi-Cachi mining areas.
  • (6) Lead Oxide Mineral Resources are reported at COVs based on 2016 actual metallurgical recoveries and 2021 smelter contracts.
  • Sierra Metals Inc. is a diversified Canadian mining company focused on the production and development of precious and base metals from its polymetallic Yauricocha Mine in Peru, and Bolivar and Cusi Mines in Mexico.